Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Fzd2 is important for skin and hair development through various signaling ways.

The study suggests that hypothyroidism may cause alopecia areata.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

A vitamin D receptor mutation causes rickets and affects immune responses.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

The study was retracted.

Pregnancy-related skin disorders need accurate diagnosis and treatment to prevent risks to the baby.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.